Skip to main content

Enliven Therapeutics, Inc.

ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001672619

In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Enliven Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
74
+13 vs. Q4 2023
Shares held
44.5M
+5.46M (+14.0%) vs. Q4 2023
Total value
$780.8M
+$241.0M (+44.6%) vs. Q4 2023
New holders
16
25 more added
Sold out
3
22 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 74 institutions
Q1 2021: 40 institutionsQ2 2021: 31 institutionsQ3 2021: 38 institutionsQ4 2021: 35 institutionsQ1 2022: 31 institutionsQ2 2022: 26 institutionsQ3 2022: 31 institutionsQ4 2022: 36 institutionsQ1 2023: 45 institutionsQ2 2023: 63 institutionsQ3 2023: 61 institutionsQ4 2023: 62 institutionsQ1 2024: 74 institutionsQ2 2024: 93 institutionsQ3 2024: 102 institutionsQ4 2024: 114 institutionsQ1 2025: 122 institutionsQ2 2025: 125 institutionsQ3 2025: 134 institutionsQ4 2025: 126 institutionsQ1 2026: 171 institutionsQ2 2026: 214 institutions
Value heldQ1 2024: $780.8M
Q1 2021: $92.9MQ2 2021: $86.3MQ3 2021: $62.5MQ4 2021: $33.6MQ1 2022: $26.2MQ2 2022: $13.1MQ3 2022: $18.8MQ4 2022: $74.7MQ1 2023: $735.0MQ2 2023: $797.9MQ3 2023: $533.8MQ4 2023: $539.8MQ1 2024: $780.8MQ2 2024: $1.13BQ3 2024: $1.22BQ4 2024: $1.12BQ1 2025: $983.9MQ2 2025: $1.19BQ3 2025: $1.22BQ4 2025: $960.9MQ1 2026: $2.43BQ2 2026: $4.06B
Institutions holding ELVN and their total value by quarter
QuarterHoldersValue
Q2 2026214$4.06B
Q1 2026171$2.43B
Q4 2025126$960.9M
Q3 2025134$1.22B
Q2 2025125$1.19B
Q1 2025122$983.9M
Q4 2024114$1.12B
Q3 2024102$1.22B
Q2 202493$1.13B
Q1 202474$780.8M
Q4 202362$539.8M
Q3 202361$533.8M
Q2 202363$797.9M
Q1 202345$735.0M
Q4 202236$74.7M
Q3 202231$18.8M
Q2 202226$13.1M
Q1 202231$26.2M
Q4 202135$33.6M
Q3 202138$62.5M
Q2 202131$86.3M
Q1 202140$92.9M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding ELVN in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC8,998,338$158.3M3.10%00.0%Unchanged
FMR LLC6,246,293$109.9M0.01%+1,085,051+21.0%Added
VR Adviser, LLC4,026,331$70.8M3.37%+1,071,429+36.3%Added
Commodore Capital LP3,973,245$69.9M4.67%+1,071,429+36.9%Added
5AM Venture Management, LLC3,835,975$67.5M15.11%−1,325,000−25.7%Reduced
Fairmount Funds Management LLC3,202,798$56.3M6.14%+1,071,429+50.3%Added
Citadel Advisors LLC2,354,403$41.4M0.04%−40,045−1.7%Reduced
Ra Capital Management, L.P.2,122,465$37.3M0.47%00.0%Unchanged
BlackRock Inc.1,813,351$31.9M0.00%−36,307−2.0%Reduced
Logos Global Management LP1,574,220$26.4M2.78%+1,267,144+412.6%Added
Vanguard Group Inc1,183,266$20.8M0.00%−47,622−3.9%Reduced
Janus Henderson Group PLC713,911$12.6M0.01%+305,397+74.8%Added
Boxer Capital, LLC671,358$11.8M0.58%+25,300+3.9%Added
State Street Corp491,848$8.65M0.00%+7,333+1.5%Added
Geode Capital Management, LLC475,456$8.36M0.00%+10,799+2.3%Added
Rock Springs Capital Management LP428,571$7.54M0.19%+428,571New
Acuta Capital Partners, LLC396,099$6.97M4.53%+272,223+219.8%Added
Woodline Partners LP395,686$6.96M0.06%00.0%Unchanged
Northern Trust Corp218,758$3.85M0.00%−6,054−2.7%Reduced
Charles Schwab Investment Management Inc159,035$2.80M0.00%+595+0.4%Added
HighVista Strategies LLC126,854$2.23M0.80%−10,387−7.6%Reduced
Baker Bros. Advisors LP114,833$2.02M0.03%+114,833New
Nuveen Asset Management, LLC82,995$1.46M0.00%−3,634−4.2%Reduced
Bank of New York Mellon Corp76,477$1.35M0.00%−3,652−4.6%Reduced
Morgan Stanley63,097$1.11M0.00%−16,424−20.7%Reduced
Exome Asset Management LLC57,635$1.01M0.87%+57,635New
Walleye Capital LLC56,763$998.5K0.01%+56,763New
BML Capital Management, LLC50,100$881.3K0.59%+100+0.2%Added
Rhumbline Advisers38,207$672.1K0.00%+864+2.3%Added
Swiss National Bank36,773$646.8K0.00%+300+0.8%Added
Diametric Capital, LP29,284$515.1K0.29%+29,284New
UBS Group AG26,835$472.0K0.00%+26,835New
Barclays PLC26,236$461.5K0.00%−15,842−37.6%Reduced
Blackstone Group Inc.25,191$443.1K0.00%+25,191New
Blue Owl Capital Holdings LP25,000$439.8K0.09%+25,000New
Exchange Traded Concepts, LLC24,691$434.3K0.01%+15,983+183.5%Added
Credit Suisse AG21,895$385.1K0.00%00.0%Unchanged
Legal & General Group Plc20,645$363.3K0.00%+980+5.0%Added
New York Life Investment Management LLC20,249$356.2K0.00%+20,249New
California State Teachers Retirement System19,141$336.7K0.00%−1,189−5.8%Reduced
American Century Companies Inc19,111$336.2K0.00%+19,111New
JPMorgan Chase & Co18,387$323.4K0.00%−5,602−23.4%Reduced
Goldman Sachs Group Inc17,273$303.8K0.00%−5,425−23.9%Reduced
Bank of America Corp16,738$294.4K0.00%−13,989−45.5%Reduced
Alliancebernstein L.P.15,990$281.3K0.00%+1,020+6.8%Added
State of Wisconsin Investment Board13,287$233.7K0.00%−4,954−27.2%Reduced
Invesco Ltd.12,489$219.7K0.00%+10.0%Added
Prelude Capital Management, LLC12,484$219.6K0.02%+12,484New
MetLife Investment Management12,345$217.1K0.00%00.0%Unchanged
American International Group, Inc.11,503$202.3K0.00%−100−0.9%Reduced
Deutsche Bank AG10,974$193.0K0.00%+343+3.2%Added
Jane Street Group, LLC10,402$183.0K0.00%−5,282−33.7%Reduced
EntryPoint Capital, LLC9,510$167.3K0.15%+9,510New
SG Americas Securities, LLC9,430$166.0K0.00%−4,071−30.2%Reduced
New York State Common Retirement Fund9,375$164.9K0.00%−24−0.3%Reduced
Wells Fargo & Company8,215$144.5K0.00%+1,057+14.8%Added
China Universal Asset Management Co., Ltd.7,952$139.9K0.02%+3,189+67.0%Added
Citigroup Inc7,833$137.8K0.00%+427+5.8%Added
Advisor Group Holdings, Inc.2,000$35.2K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,928$33.9K0.00%00.0%Unchanged
Metropolitan Life Insurance Co1,279$22.5K0.00%00.0%Unchanged
Royal Bank of Canada1,129$20.0K0.00%−6,862−85.9%Reduced
Quest Partners LLC850$15.0K0.00%+850New
Amalgamated Bank787$14.0K0.00%−1,249−61.3%Reduced
Tower Research Capital LLC (TRC)506$8.90K0.00%−4,979−90.8%Reduced
Daiwa Securities Group Inc.152$3.00K0.00%+152New
GAMMA Investing LLC53$9320.00%+16+43.2%Added
Nisa Investment Advisors, LLC15$2640.00%+6+66.7%Added
Russell Investments Group, Ltd.12$2110.00%00.0%Unchanged
The PNC Financial Services Group, Inc.8$1410.00%+3+60.0%Added
Farther Finance Advisors, LLC6$1130.00%00.0%Unchanged
Nelson, Van Denburg & Campbell Wealth Management Group, LLC5$870.00%+5New
Covestor Ltd1$00.00%00.0%Unchanged
CWM, LLC4$00.00%+4New
Mirae Asset Global Investments Co., Ltd.0$00.00%−12,305−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−10,095−100.0%Sold out
AJOVista, LLC0$00.00%−2,046−100.0%Sold out
Baystate Wealth Management LLC––––Not filed